P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
The role of p53 family proteins, both in the pathogenesis of chronic lymphoproliferative disorders, and in aspects of the growi ng interest in thetherapeutic potential of so-called small molecules capable of influencing the regulatory "relationship" of p53, MDM2, p21 and P UMA is currently...
Saved in:
| Main Authors: | P. M. Kondratovskiy, A. I. Dubikov, A. Yu. Doroshevskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/92 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apoptosis as a factor for organizing autoimmune inflammation in rheumatoid arthritis
by: A. I. Dubikov, et al.
Published: (2019-09-01) -
Resveratrol targeting MDM2/P53/PUMA axis to inhibit colonocyte apoptosis in DSS-induced ulcerative colitis mice
by: Rui Tang, et al.
Published: (2025-04-01) -
Chronic lymphoproliferative diseases: survival in cohort study of 310 patients (single-center study results and literature data)
by: V. P. Pop, et al.
Published: (2015-01-01) -
Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
by: Donald Pasquale
Published: (2014-08-01) -
Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
by: Ye Huang, et al.
Published: (2025-04-01)